MedPath

TRACE ELEMENTS FOR INJECTION - LIQ IV

TRACE ELEMENTS FOR INJECTION - LIQ IV

Discontinued
DIN Number

02137143

Drug Class

Human

Market Date

Jun 15, 1998

Company
HC

faulding (canada) inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02137143
AIG Number0415276001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05XA31 ELECTROLYTES IN COMB WITH OTHER DRUGS
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification40:12.00
Health Canada Classification

ACTIVE INGREDIENTS (4)

CHROMIC CHLORIDEActive
Strength: .102 MG / 5 ML
Monograph: CHROMIC CHLORIDE
CUPRIC CHLORIDEActive
Strength: 2.68 MG / 5 ML
Monograph: CUPRIC CHLORIDE
MANGANESE CHLORIDEActive
Strength: 1.44 MG / 5 ML
Monograph: MANGANESE CHLORIDE
ZINC CHLORIDEActive
Strength: 10.42 MG / 5 ML
Monograph: ZINC CHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.